3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Unknown
1
Completed
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Breast Neoplasms
7
Pain, Postoperative
5
Leiomyoma
3
Carcinoma, Hepatocellular
3
Stomatitis
2
Pituitary Neoplasms
2
Ovarian Neoplasms
2
Neoplasms
2
Hematologic Neoplasms
2
Head and Neck Neoplasms
2
Chronic Pain
2
Uterine Cervical Neoplasms
1
Ulcer
1
Supratentorial Neoplasms
1
Sleep Wake Disorders
1
Rhabdomyosarcoma, Alveolar
1
Retinoblastoma
1
Rectal Neoplasms
1
Pulmonary Atelectasis
1
Pleural Effusion, Malignant
1
Pituitary Diseases
1
Phlebitis
1
Peripheral Nervous System Diseases
1
Patient Participation
1
Pancreatic Ductal Adenocarcinoma
1
Non-functioning Pituitary Adenoma
1
Neurotoxicity Syndromes
1
Neuralgia
1
Neoplasm Metastasis
1
Multiple Myeloma
1
Interventions
Paclitaxel
16
Carboplatin
15
Bevacizumab
7
Hyperthermic Intraperitoneal Chemotherapy
5
Cisplatin
4
Taxes
3
Gemcitabine
3
Cytoreduction Surgical Procedures
3
Chemotherapy, Adjuvant
3
oregovomab
2
niraparib
2
fluzoparib
2
Topotecan
2
ST 1481
2
Neoadjuvant Therapy
2
Methods
2
Immunohistochemistry
2
Ifosfamide
2
Gene Expression Profiling
2
Filgrastim
2
Educational Status
2
Early Intervention, Educational
2
Amplified Fragment Length Polymorphism Analysis
2
rucaparib
1
pembrolizumab
1
paclitaxel poliglumex
1
olaparib
1
navicixizumab
1
mirvetuximab soravtansine
1
liposomal doxorubicin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Unknown
×
Fallopian Tube Neoplasms
×
Saline Solution
×
Clear all
NCT04201561
2023-06-26
SELENIUM
Seoul National University Hospital
Phase 3
Unknown
68 enrolled